Cargando…

Lovastatin Treatment of a Patient with a De Novo SYNGAP1 Protein Truncating Variant

Detalles Bibliográficos
Autores principales:	Cook, Edwin H., Masaki, Jayson T., Guter, Stephen J., Najjar, Fedra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533776/ https://www.ncbi.nlm.nih.gov/pubmed/30901256 http://dx.doi.org/10.1089/cap.2018.0159

Ejemplares similares

Identification and functional characterization of de novo variant in the SYNGAP1 gene causing intellectual disability
por: Li, Boxuan, et al.
Publicado: (2023)

Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
por: Carvill, Gemma L., et al.
Publicado: (2013)

Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism
por: Chen, Rui, et al.
Publicado: (2017)

Context-dependent hyperactivity in syngap1a and syngap1b zebrafish autism models
por: Sumathipala, Sureni H., et al.
Publicado: (2023)

The SYNGAP1 3′UTR Variant in ALS Patients Causes Aberrant SYNGAP1 Splicing and Dendritic Spine Loss by Recruiting HNRNPK
por: Yokoi, Satoshi, et al.
Publicado: (2022)

SYNGAP1: Mind the Gap
por: Jeyabalan, Nallathambi, et al.
Publicado: (2016)

A novel UBAP1 truncated variant in a Chinese family with hereditary spastic paraplegia
por: Wei, Qiao, et al.
Publicado: (2022)

De novo, heterozygous, loss‐of‐function mutations in SYNGAP1 cause a syndromic form of intellectual disability
por: Parker, Michael J., et al.
Publicado: (2015)

The burden of rare protein-truncating genetic variants on human lifespan
por: Liu, Jimmy Z., et al.
Publicado: (2022)

Adult Phenotype of SYNGAP1-DEE
por: Rong, Marlene, et al.
Publicado: (2023)

Spinocerebellar Ataxia 48 Patient With a Novel De Novo Variant of STUB1
por: Choi, Soyoun, et al.
Publicado: (2022)

Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Phrase truncation in PubMed searches
por: Shanman, Roberta
Publicado: (2017)

Is it time to truncate the trusted ‘3-T Strategy’
por: Acharya, K.V., et al.
Publicado: (2021)

A novel truncating variant in the LAMP2 gene in a young woman with hypertrophic cardiomyopathy and variable clinical course in the family
por: Michalak, Ewa, et al.
Publicado: (2019)

Phenotypes in Children With SYNGAP1 Encephalopathy in China
por: Zhang, Huiting, et al.
Publicado: (2021)

Refining the role of de novo protein truncating variants in neurodevelopmental disorders using population reference samples
por: Kosmicki, Jack A., et al.
Publicado: (2017)

Response to “Phrase truncation in PubMed searches”
por: Duffy, Steven, et al.
Publicado: (2017)

De novo Leukemic Variant of Mast Cell Leukemia With KIT D816V
por: Bang, Hae In, et al.
Publicado: (2015)

Tremulous spastic ataxia in a patient with a homozygous truncating SYNE1 variant
por: Spagnolo, Francesca, et al.
Publicado: (2023)

De novo variant of SETD1A causes neurodevelopmental disorder with dysmorphic facies: A case report
por: Zhang, Jia, et al.
Publicado: (2021)

Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report
por: Prchalova, Darina, et al.
Publicado: (2017)

Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations
por: Liu, Dongjing, et al.
Publicado: (2023)

Mouse models of SYNGAP1-related intellectual disability
por: Araki, Yoichi, et al.
Publicado: (2023)

Mouse models of SYNGAP1-related intellectual disability
por: Araki, Yoichi, et al.
Publicado: (2023)

Utility of platelet cross-matching in a case of neonatal alloimmune thrombocytopenia associated with a de novo MECOM variant
por: Datta, Suvro Sankha, et al.
Publicado: (2021)

Zn(2+) reverses functional deficits in a de novo dopamine transporter variant associated with autism spectrum disorder
por: Hamilton, Peter J, et al.
Publicado: (2015)

SYNGAP1 encephalopathy: A distinctive generalized developmental and epileptic encephalopathy
por: Vlaskamp, Danique R.M., et al.
Publicado: (2019)

SHP2-mediated mitophagy boosted by lovastatin in neuronal cells alleviates parkinsonism in mice
por: Liu, Wen, et al.
Publicado: (2021)

SynGAP Regulates Protein Synthesis and Homeostatic Synaptic Plasticity in Developing Cortical Networks
por: Wang, Chih-Chieh, et al.
Publicado: (2013)

X linked Infantile Epileptic Encephalopathy due to SMC1A Truncating Mutation
por: Naik, Neeta Ajit, et al.
Publicado: (2021)

SynGAP isoforms exert opposing effects on synaptic strength
por: McMahon, A.C., et al.
Publicado: (2012)

Comprehensive behavioral analysis of heterozygous Syngap1 knockout mice
por: Nakajima, Ryuichi, et al.
Publicado: (2019)

Cyfip1 Regulates SynGAP1 at Hippocampal Synapses
por: Sahasrabudhe, Abhishek, et al.
Publicado: (2021)

Highly Aggressive de novo Aleukemic Variant of Mast Cell Leukemia Without KIT D816V Mutation
por: Suh, Myung Chul, et al.
Publicado: (2017)

Hyperexcitability and translational phenotypes in a preclinical model of SYNGAP1 mutations
por: Silverman, Jill L., et al.
Publicado: (2023)

Case report: A de novo NSD2 truncating variant in a child with Rauch-Steindl syndrome
por: Yang, Qi, et al.
Publicado: (2023)

Does a truncated form of the transcription factor Ets1 exist in breast cancer cells?
por: Dittmer, J
Publicado: (2006)

Variants in Adjacent Oxytocin/Vasopressin Gene Region and Associations with ASD Diagnosis and Other Autism Related Endophenotypes
por: Francis, Sunday M., et al.
Publicado: (2016)

CHILD syndrome: successful treatment of skin lesions with topical lovastatin and cholesterol lotion
por: Sandoval, Karina Romero, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n2qr7cpatgp1o1go2soat2gkb4